Page 83 - Read Online

Grynkiewicz. J Cancer Metastasis Treat 2020;6:48 I http://dx.doi.org/10.20517/2394-4722.2020.112 Page 9 of 10

19. Messina MA. Brief historical overview of the past two decades of soy and isoflavone research. J Nutr 2010;140:1350S-4.
20. Ko KP. Isoflavones: chemistry, analysis, functions and effects on health and cancer. Asian Pac J Cancer Prev 2014;15:7001-10.
21. Szeja W, Grynkiewicz G, Rusin A. Isoflavones, their glycosides and glycoconjugates. Synthesis and biological activity. Curr Org Chem
2017;21:218-35.
22. Venkataraman K. Flavones and isoflavones. Progr Chem Org Nat Prod 1959;17:2-69.
23. Wong E. Structural and biogenetic relationships of isoflavonoids. Progr Chem Org Nat Prod 1970;28:1-73.
24. Flavonoids in Health and Disease, Second Edition. Catherine A, Rice-Evans C, Lester Packer L, editors. Boca Raton, FL: CRC Press;
2003.
25. The Science of Flavonoids. Grotewold E, editor. New York: Springer Science + Business Media; 2006.
26. Flavonoids Chemistry, Biochemistry and Applications. Andersen OM, Markham KR, editors. Boca Raton, FL: CRC Taylor & Francis;
2006.
27. Flavonoids: Biosynthesis, Biological Effects and Dietary Sources. Keller RB, editor. New York: Nova Science Publishers, Inc.; 2009.
28. Vicente O, Bosatu M. Flavonoids: antioxidant compounds for plant defence...and for a healthy human diet. Not Bot Horti Agrobo
2018;46:14-21.
29. Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci 2016;5:e47.
30. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. Sci World J 2013;2013:1-16.
31. Perez-vizcaino F, Fraga CG. Research trends in flavonoids and health. Arch Biochem Biophys 2018;646:107-12.
32. Naoumkina MA, Zhao Q, Gallego-giraldo L, Dai X, Zhao PX, Dixon RA. Genome-wide analysis of phenylpropanoid defence pathways:
phenylpropanoid defence pathways. Mol Plant Pathol 2010;11:829-46.
33. Prasad S, Phromnoi K, Yadav V, Chaturvedi M, Aggarwal B. Targeting inflammatory pathways by flavonoids for prevention and treatment
of cancer. Planta Med 2010;76:1044-63.
34. Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011;82: 513-23.
35. Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, Borrelli F. Novel insights into the pharmacology of flavonoids:
pharmacology of flavonoids. Phytother Res 2013;27:1588-96.
36. Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and other phenolic compounds from medicinal plants for
pharmaceutical and medical aspects: an overview. Medicines (Basel) 2018;5:93.
37. Ravishankar D, Rajora AK, Greco F, Osborn HMI. Flavonoids as prospective compounds for anti-cancer terapy. Int J Biochem Cell Biol
2013;45:2821-31.
38. Raffa D, Maggio B, Raimondi MV, Plescia F, Daidone G. Recent discoveries of anticancer flavonoids. Eur J Med Chem 2017;142:213-28.
39. Rodríguez-garcía C, Sánchez-quesada C, Gaforio JJ. Dietary flavonoids as cancer chemopreventive agents: an updated review of human
studies. Antioxidants 2019;8:137.
40. Abotaleb M, Samuel S, Varghese E, et al. Flavonoids in cancer and apoptosis. Cancers 2019;11:28.
41. Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients 2020;12:457.
42. Thilakarathna S, Rupasinghe H. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013;5:3367-87.
43. Rodriguez-mateos A, Vauzour D, Krueger CG, et al. Bioavailability, bioactivity and impact on health of dietary flavonoids and related
compounds: an update. Arch Toxicol 2014;88:1803-53.
44. Nicolle E, Souard F, Faure P, Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest
and structure-activity relationship. Curr Med Chem 2011;18:2661-72.
45. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Asp Med 2013;34:121-38.
46. Aguillón AR, Mascarello A, Segretti ND, et al. Synthetic strategies toward SGLT2 Inhibitors. Org Process Res Dev 2018;22:467-88.
47. Balentine DA, Dwyer JT, Erdman JW, et al. Recommendations on reporting requirements for flavonoids in research. Am J Clin Nutr
2015;101:1113-25.
48. Harnly J. Importance of accurate measurements in nutrition research: dietary flavonoids as a case study. Adv Nutr 2016;7:375-82.
49. Maggiora G, Vogt M, Stumpfe D, Bajorath J. Molecular similarity in medicinal chemistry miniperspective. J Med Chem 2014;57:3186-204.
50. Popelier P, Smith P. QSAR models based on quantum topological molecular similarity. Eur J Med Chem 2006;41:862-73.
51. Renner S, Schneider G. Scaffold-hopping potential of ligand-based similarity concepts. ChemMedChem 2006;1:181-5.
52. Scalbert A, Andres-lacueva C, Arita M, et al. Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem
2011;59:4331-48.
53. Wishart DS, Mandal R, Stanislaus A, Ramirez-Gaona M. Cancer metabolomics and the human metabolome database. Metabolites
2016;6:10.
54. Sebastian RS, Enns CW, Goldman JD, et al. New, publically available flavonoid data products: valuable resources for emerging science. J
Food Compos Anal 2017;64:68-72.
55. Veitch NC. Isoflavonoids of the leguminosae. Nat Prod Rep 2007;24:417-64.
56. Adams NR. Permanent infertility in ewes exposed to plant oestrogens. Aust Vet J 1990; 67:197-201.
57. Adams NR. Detection of the effects of phytoestrogens on sheep and cattle. J Anim Sci 1995;73:1509-15
58. Jefferson WN, Patisaul HB, Williams CJ. Reproductive consequences of developmental phytoestrogen exposure. Reproduction
2012;143:247-60.
59. Douglas C, Johnson S, Arjmandi B. Soy and its isoflavones: the truth behind the science in breast cancer. Anticancer Agents Med Chem
2013;13:1178-87.
60. Zaheer K, Humayoun Akhtar M. An updated review of dietary isoflavones: nutrition, processing, bioavailability and impacts on human